Prevalence of Carpal Tunnel Syndrome in Diabetic Patients with and without Metabolic Syndrome (
DOI:
https://doi.org/10.12970/2310-9971.2016.04.01.2Keywords:
Prevalence, Carpal Tunnel Syndrome, Metabolic Syndrome, Diabetes.Abstract
Background and Objectives: Carpal tunnel syndrome (CTS) is defined as the impaction of the median nerve in the carpal tunnel of the wrist. Metabolic disorders are closely associated with CTS; and metabolic syndrome (MS) is found to be more in patients with CTS. Metabolic syndrome is highly prevalent in patients with type 2 diabetes. This study was conducted to determine the prevalence of CTS in diabetic patients with and without metabolic syndrome. Material and Methods: In this cross-sectional study, 439 diabetic patients that participated in the study of risk factors for coronary artery disease in Kerman (KERCADRS) were enrolled. People with positive clinical symptoms for CTS and a positive Boston questionnaire, were referred to a neurologist for further diagnosis. For the diagnosis of metabolic syndrome, three criteria (ATPIII, IDF and new criteria in Kerman) were used. Also, electro-diagnostic tests were used for the diagnosis of CTS. Data were analyzed by independent t-test and chi square test in SPSS20. Results: The prevalence of CTS in diabetic patients was 24.23%. The prevalence of the disorder in male and female patients was 16.21% and 30.65%, respectively. The results showed that there is no significant difference in the prevalence of CTS in diabetic people with and without metabolic syndrome, in overall as well as sex subgroups. Discussion and Conclusion: The higher prevalence of CTS in diabetic patients in this study compared to other studies shows the lack of prevention and case finding in diabetic patients. Therefore, screening, educating and informing at risk people about the disease is necessary.References
[1] Rayegani M, Rad MM, Bahrami M, Pour DE, Valaee N. Prevalence of carpal tunnel syndrome and related factors In patients with upper extremity pain. Journal of ShahidBeheshti University of Medical Sciences 2009; 70(4): 219-23.
[2] MayoClinic. Carpal Tunnel Syndrome. Available at http://wwwmayocliniccom/health/carpal-tunnel-syndrome. 2012.
[3] de Krom MC KP, Kester AD, Thijs CT, Boekkooi PF, Spaans F. Carpal tunnel syndrome: Prevalence in the general population. J Clin Epidemiol 1992; 45(4): 373-6. http://dx.doi.org/10.1016/0895-4356(92)90038-o
[4] Thomsen N. Carpal tunnel syndrome and diabetes. Surgical outcome and nerve pathology. Lund University 2009.
[5] Rosemont I. Carpal Tunnel Syndrome.American Academy of Orthopaedic Surgeons 2012; 9195(3): 4-6.
[6] Yazdanpanah PAS, Mousavizadeh A, Ghaffari P, Khosravi Z, Khademi A. Prevalence of Carpal Tunnel Syndrome in Women of Boyerahmad Township. Journal of Zanjan University of Medical Sciences 2011; 79(20): 103-11.
[7] Balci K, Utku U. Carpal tunnel syndrome and metabolic syndrome. Acta Neurologicascandinavica 2007; 116(2): 113- 7. http://dx.doi.org/10.1111/j.1600-0404.2007.00797.x
[8] Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet 2005; 365(9468): 1415-28. http://dx.doi.org/10.1016/S0140-6736(05)66378-7
[9] Rutaihwa M. Prevalence and risk factors of metabolic syndrome among Students at the university of dar-es-salaam 2011; 20(11): 1-60.
[10] Dhanaraj E, Bhansali A, Jaggi S, et al. Predictors of metabolic syndrome in Asian north Indians with newly detected type 2 diabetes. Indian Journal of Medical Research 2009; 129(5): 506-14.
[11] Basol G, Barutcuoglu B, Cakir Y, et al. Diagnosing metabolic syndrome in type 2 diabetic Turkish patients: comparison of AHA/NHLBI and IDF definitions. Bratisl Lek Listy 2011; 112(5): 253-9.
[12] Rashidi H, Ghaderian B, Shahbazian HB, Latifi MK, Arghideh M. Prevalence of metabolic syndrom and its predicting factors in type 2 diabetic patients in ahvaz. Jundishapur Scientific Medical Journal 2012; 11(1): 163-75.
[13] Song SH, Hardisty CA. Diagnosing metabolic syndrome in type 2 diabetes: does it matter? QJM 2008; 101(6): 487-91. http://dx.doi.org/10.1093/qjmed/hcn034
[14] Najafipour H, Mirzazadeh A, Haghdoost AA, Shadkam M, Afshari M, et al. Coronary Artery Disease Risk Factors in an urban and pri-urban setting (KERCADR Study): Methodology and Preliminary Report. Iran J Public Health 2012; 41(9): 86- 92.
[15] Heng D, Ma S, Lee JJM, et al. Modification of the NCEP ATPIII definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis 2006; 186: 367-73. http://dx.doi.org/10.1016/j.atherosclerosis.2005.07.020
[16] Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295-300. http://dx.doi.org/10.5551/jat.12.295
[17] Gozashti M, Fedaei N, Shojaei M and Najafipour H. Determination of Most Suitable Cut off Point Of Waist Circumference for Diagnosis of Metabolic Syndrome inKerman. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2014; 8(1): 8-12. http://dx.doi.org/10.1016/j.dsx.2013.10.022
[18] Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002; 25(3): 565-9. http://dx.doi.org/10.2337/diacare.25.3.565
[19] Forough B. carpal tunnel syndrome. Teymourzadeh 2001.
[20] Atroshi I, Gummesson C, Johnsson R. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999; 282: 153-8. http://dx.doi.org/10.1001/jama.282.2.153
[21] Schiavon F, Circhetta C, Dani L. The diabetic hand. Reumatismo 2004; 56(3): 139-142.
[22] Geoghegan JM, Clark DI, Bainbridge LC, Smith C, Hubbard R. Risk factors in carpal tunnel syndrome. J Hand Surg 2004; 29(4): 315-320. http://dx.doi.org/10.1016/j.jhsb.2004.02.009
[23] Phalen GS. Reflections on 21 years’ experience with the carpal tunnel syndrome. JAMA 1970; 212: 1365-67. http://dx.doi.org/10.1001/jama.1970.03170210069012
[24] Samadi S, Ebrahimi H, Khanjani N, Ebrahimi F. Evaluation of findings in carpal tunnel syndrome during surgery in patients referred to reconstructive surgery ward. Zahedan J Res Med Sci 2015; 17(1): 34-36.
[25] Tanzer R. The carpal tunnel syndrome: A clinical and anatomical study. J Bone Joint Surg Am 1959; 41(4): 626- 634.
[26] Ander B, Yalasa E, Selasuk Bn, Kurtaran A, Akya Mf. Carpal tunnel syndrome and metabolic syndrome co-occurrence. Rheumatology International 2012; 33(3): 583-6. http://dx.doi.org/10.1007/s00296-012-2417-1
[27] American College of Rheumatology. Carpal Tunnel Syndrome: Patient Fact Sheet. Available at http://www.rheumatology.org. Last accessed March 26, 2012.
[28] Karpitskaya Y, Novak CB, Mackinnon SE. Prevalence of smoking, obesity, diabetes mellitus and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg 2002; 48(3): 269-273. http://dx.doi.org/10.1097/00000637-200203000-00007
[29] van Dijk MAJ, Reitsma JB, Fischer JC, Sanders GTB. Indications for requesting laboratory tests for concurrent diseases in patients with carpal tunnel syndrome: a systematic review. Clin Chem 2003; 49(9): 1437-1444. http://dx.doi.org/10.1373/49.9.1437
[30] Foroozanfar Z, Najafipour H, Khanjani N, Bahrampour A, Ebrahimi H. The Prevalence of Metabolic Syndrome According to Different Criteria and its Associated Factors in Type 2 Diabetic Patients in Kerman, Iran. Iranian Journal of Medical Sciences 2015; 40(6): 522-525.
[31] Rempel D, Evanoff B, Amadio P C, Krom M de, Franklin G, Franzblau A, et al. Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. American Journal of Public Health October 1998; 88(10): 1447-1451. http://dx.doi.org/10.2105/AJPH.88.10.1447
